98 related articles for article (PubMed ID: 8158888)
1. Prevention of progression in non-diabetic chronic renal failure.
Becker GJ; Whitworth JA; Ihle BU; Shahinfar S; Kincaid-Smith PS
Kidney Int Suppl; 1994 Feb; 45():S167-70. PubMed ID: 8158888
[TBL] [Abstract][Full Text] [Related]
2. [Progression of chronic renal insufficiency].
Rossert J; Fischer E; Venetz JP
Nephrologie; 1999; 20(1):3-7. PubMed ID: 10081030
[No Abstract] [Full Text] [Related]
3. Glomerular hypertension in the progression of chronic renal failure: role of low protein diet and angiotensin converting enzyme inhibitors.
Cappelli P; Del Rosso G; Di Paolo B; Evangelista M; Albertazzi A
Scand J Urol Nephrol Suppl; 1988; 108():25-30. PubMed ID: 3163827
[No Abstract] [Full Text] [Related]
4. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
Guidi E; Minetti EE; Cozzi MG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
[TBL] [Abstract][Full Text] [Related]
5. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A
J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716
[TBL] [Abstract][Full Text] [Related]
6. Kidney protection: how to prevent or delay chronic renal failure.
Steinman TI
Geriatrics; 1996 Aug; 51(8):28-35. PubMed ID: 8707068
[TBL] [Abstract][Full Text] [Related]
7. [How to slow the progression of chronic renal insufficiency].
Rossert J; Ronco P
Rev Prat; 2001 Feb; 51(4):378-84. PubMed ID: 11355601
[TBL] [Abstract][Full Text] [Related]
8. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
9. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
Jafar TH; Schmid CH; Stark PC; Toto R; Remuzzi G; Ruggenenti P; Marcantoni C; Becker G; Shahinfar S; De Jong PE; De Zeeuw D; Kamper AL; Strangaard S; Levey AS
Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
[TBL] [Abstract][Full Text] [Related]
10. [ACE inhibitors and the kidney].
Hörl WH
Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
[TBL] [Abstract][Full Text] [Related]
11. Low-protein diet supplemented by keto acids in chronic renal failure: a prospective controlled study.
Gretz N; Korb E; Strauch M
Kidney Int Suppl; 1983 Dec; 16():S263-7. PubMed ID: 6376916
[TBL] [Abstract][Full Text] [Related]
12. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
13. Long-term renoprotective effect of combination therapy with prostaglandin E1 and angiotensin-converting enzyme inhibitor in patients with chronic renal failure.
Nakayama Y; Nonoguchi H; Kiyama S; Kohda Y; Inoue T; Tomita K
Hypertens Res; 2005 Sep; 28(9):733-9. PubMed ID: 16419646
[TBL] [Abstract][Full Text] [Related]
14. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
Imai E; Takenaka M; Isaka Y; Moriyama T; Akagi Y; Kakuchi J; Fujii T; Ito T; Hori M; Horio M; Syoji T; Tsubakihara Y
Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation.
Kanno Y; Okada H; Yamaji Y; Nakazato Y; Suzuki H
QJM; 2005 Mar; 98(3):199-203. PubMed ID: 15728401
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Cantarovich F; Rangoonwala B
Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
[TBL] [Abstract][Full Text] [Related]
18. Compliance and effects of nutritional treatment on progression and metabolic disorders of chronic renal failure.
Combe C; Deforges-Lasseur C; Caix J; Pommereau A; Marot D; Aparicio M
Nephrol Dial Transplant; 1993; 8(5):412-8. PubMed ID: 8393545
[TBL] [Abstract][Full Text] [Related]
19. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
Omata K; Kanazawa M; Sato T; Abe F; Saito T; Abe K
Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
